Catalent, a leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.   The project has seen the site increase by approximately 30,000 square feet (approximately 2,800 square meters), which has allowed the installation of additional refrigerated (between 2 and 8 d...